Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Patent
1993-07-09
1994-10-25
Walsh, Stephen G.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
530826, 4241861, 4242321, 536 2372, 930220, C07K 1300, C07K 1504
Patent
active
053590392
ABSTRACT:
Isolated viral proteins, and pharmaceutical compositions made therefrom, are disclosed which are capable of binding to Tumor Necrosis Factor, thereby functioning as Tumor Necrosis Factor antagonists. Also disclosed are processes for preparing isolated viral protein cytokine antagonists.
REFERENCES:
patent: 5075236 (1991-12-01), Yone et al.
McFadden, G. in Virus Diseases in Laboratory and Captive Animals; Darai, G. (ed), Martinus Nijoff, Publishers, Boston; pp. 37-61 (1988).
Horton et al., J. Virol. 65:2629-2639; 1991.
Goodwin and Smith, in: Contributions to Cellular and Molecular Endocrinology Henry and Norman (eds); University of California, Riverside; pp. 43-48; 1991.
Goebel et al., Virology 179:247-266; 1990.
Pickup et al., Proc. Natl. Acad. Sci. USA 81:6817-6821; 1984.
Smith et al., "T2 Open Reading Frame from the Shope Fibroma Virus . . . " Biochem. Biophys. Res. Comm. 176(1):335-342 (Apr. 1991).
Howard et al., "Vaccinia Virus . . . ORF Related to the Tumor Necrosis Factor Receptor Family", Virol. 180:633-647 (Feb. 1991).
Upton et al., "Myxoma Virus Expresses a Secreted Protein . . . " Virol. 184:370-382 (Sep. 1991).
Sprang et al., "The divergent receptors for TNF" TIBS 15:366-368 (Oct. 1990).
Kohno et al., "A second tumor necrosis factor receptor gene . . . " PNA 87:8331-8335 (Nov. 1990).
Upton et al., "Tumorigenie Poxviruses: Genomic Organization . . . " Virol. 160:20-30 (Sep. 1987).
Smith et al., "A Receptor for Tumor Necrosis Factor Defines an Unusual Family of Cellular and Viral Proteins" Science 248:1019-1023 (May 1990).
Traktman, "Poxviruses: An Emerging Portrait of Biological Strategy", Cell 62:621-626 (Aug. 1990).
Goodwin Raymond G.
Smith Craig A.
Hallquist Scott G.
Immunex Corporation
Perkins Patricia Anne
Walsh Stephen G.
Wight Christopher L.
LandOfFree
Isolated poxvirus A53R-equivalent tumor necrosis factor antagoni does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated poxvirus A53R-equivalent tumor necrosis factor antagoni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated poxvirus A53R-equivalent tumor necrosis factor antagoni will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-136277